ClinConnect ClinConnect Logo
Search / Trial NCT04790487

Chlorpheniramine Maleate Nasal Spray for Chronic Rhinitis

Launched by LARKIN COMMUNITY HOSPITAL · Mar 9, 2021

Trial Information

Current as of June 03, 2025

Withdrawn

Keywords

Nasal Spray Chlorpheniramine

ClinConnect Summary

Allergic rhinitis is defined as the symptoms of sneezing, nasal itching, airflow obstruction and, mostly, clear nasal discharge caused by IgE-mediated reactions against inhaled allergens and involving mucosal inflammation driven by T cells (Th2) auxiliary type 2. pollens and molds, as well as allergens from perennial interiors, such as dust mites, pets, pests and some molds. The pattern of dominant allergens depends on the geographic region and degree of urbanization, but the general prevalence of sensitization to allergens does not vary among census districts in the United States.2 Sensiti...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. No oral steroids
  • 2. No oral antihistamine
  • 3. No Nafasoline If the patient needs rescue treatment, he will go to the intervention arm with chlorpheniramine or with the combination of chlorpheniramine and fluticasone. If a participant experienced a severe acute nasal block, the investigator could authorize the use of a short course of oxymetazoline spray for a maximum of 3 days and a maximum total of 1 day during the treatment period. Oxymetazoline should not be used within 24 hours of a scheduled visit during the study.
  • Exclusion Criteria:
  • 1. Large (grade 3) polyps, indicating severe nasal obstruction
  • 2. Surgical treatment for nasal polyps during the last 3 months
  • 3. Cystic fibrosis
  • 4. Purulent nasal infection
  • 5. Allergic rhinitis
  • 6. Any disease likely to interfere with the study parameters or which gave evidence of any serious or unstable concurrent disease or psychological disorder

About Larkin Community Hospital

Larkin Community Hospital is a leading healthcare institution dedicated to providing comprehensive medical services and advancing clinical research. With a commitment to enhancing patient care through innovative therapies and evidence-based practices, the hospital actively engages in clinical trials that explore new treatment options across various medical disciplines. Larkin Community Hospital's experienced research team collaborates with healthcare professionals and regulatory bodies to ensure the highest standards of safety and efficacy in all clinical studies, ultimately aiming to improve health outcomes and contribute to the scientific community.

Locations

South Miami, Florida, United States

Patients applied

0 patients applied

Trial Officials

Marcos A Sanchez-Gonzalez

Principal Investigator

Larkin Health System

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials